Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2006, p. 1518-1521, Vol. 50, No. 4
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.4.1518-1521.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605,1 Roche, Palo Alto, California2
Received 22 July 2005/ Returned for modification 9 September 2005/ Accepted 12 January 2006
In our previous crystallographic studies of human immunodeficiency virus type 1 (HIV-1) protease-substrate complexes, we described a conserved "envelope" that appears to be important for substrate recognition and the selection of drug-resistant mutations. In this study, the complex of HIV-1 protease with the inhibitor RO1 was determined and comparison with the substrate envelope provides a rationale for mutational patterns.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»